ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Cesium carbonate → N-Cyclopropyl-3-fluoro-5-(2-{[1-(hydroxymethyl)cyclopropyl]methyl}-4-{[(3S)-3-methylpiperazin-1-yl]methyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-4-methylbenzamide

HRID 906438
印刷

反応式

HRID 906438 の反応式
Br[C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[C:8](=[O:12])[NH:7][CH:6]=[C:5]2[CH2:13][N:14]1[CH2:19][CH2:18][N:17](C(OC(C)(C)C)=O)[C@@H:16]([CH3:27])[CH2:15]1.CS(O[CH2:33][C:34]1([CH2:37][O:38][Si](C(C)(C)C)(C)C)[CH2:36][CH2:35]1)(=O)=O.C(=O)([O-])[O-].[Cs+].[Cs+].[CH:52]1([NH:55][C:56](=[O:74])[C:57]2[CH:62]=[C:61](B3OC(C)(C)C(C)(C)O3)[C:60]([CH3:72])=[C:59]([F:73])[CH:58]=2)[CH2:54][CH2:53]1>CN(C=O)C.O>[CH:52]1([NH:55][C:56](=[O:74])[C:57]2[CH:62]=[C:61]([C:2]3[CH:3]=[C:4]4[C:9](=[CH:10][CH:11]=3)[C:8](=[O:12])[N:7]([CH2:33][C:34]3([CH2:37][OH:38])[CH2:35][CH2:36]3)[CH:6]=[C:5]4[CH2:13][N:14]3[CH2:19][CH2:18][NH:17][C@@H:16]([CH3:27])[CH2:15]3)[C:60]([CH3:72])=[C:59]([F:73])[CH:58]=2)[CH2:53][CH2:54]1
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 10796Cesium carbonateHCID 21914563N-cyclopropyl-3-fluoro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamideHCID 59000927[1-({[tert-Butyl(dimethyl)silyl]oxy}methyl)cyclopropyl]methyl methanesulfonateHCID 67438201tert-Butyl (2S)-4-[(6-bromo-1-oxo-1,2-dihydroisoquinolin-4-yl)methyl]-2-methylpiperazine-1-carboxylate

生成物 1

HCID 59285271
N-Cyclopropyl-3-fluoro-5-(2-{[1-(hydroxymethyl)cyclopropyl]methyl}-4-{[(3S)-3-methylpiperazin-1-yl]methyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-4-methylbenzamide
収率 15.8%

試薬・触媒・溶媒 2

HCID 962Water溶媒HCID 6228Dimethylformamide溶媒

反応条件

温度
75 °C

実験手順

A solution of tert-butyl (2S)-4-[(6-bromo-1-oxo-1,2-dihydroisoquinolin-4-yl)methyl]-2-methylpiperazine-1-carboxylate (Example 34b, 0.26 g) dissolved in DMF (5 mL) was treated with [1-({[tert-butyl(dimethyl)silyl]oxy}methyl)cyclopropyl]methyl methanesulfonate (example 34d, 0.351 g) and cesium carbonate (0.582 g) under nitrogen. The resulting mixture was stirred at 75° C. for 3 h. The mixture was treated with N-cyclopropyl-3-fluoro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide (0.266 g) and Pd-118 (0.019 g) before heating at 80° C. for 1 h. The reaction mixture was diluted with water (250 mL), and extracted with ethyl acetate (250 mL). The organic was dried (MgSO4), filtered and evaporated. The crude product was purified (SiO2 chromatography, elution 100% ethyl acetate). Pure fractions of [tert-butyl (2S)-4-[(6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-2-{[1-(hydroxymethyl)cyclopropyl]methyl}-1-oxo-1,2-dihydroisoquinolin-4-yl)methyl]-2-methylpiperazine-1-carboxylate] were evaporated to dryness. The mixture was treated with trifluoroacetic acid/DCM (1:1, 10 mL) and stirred for 1 h at room temperature. The mixture was evaporated to dryness and the crude material was dissolved in acetonitrile (25 mL) and loaded on to a 10 g SCX cartridge. The impurities were washed through with acetonitrile (50 mL) and discarded. The product was eluted with 1 N methanolic ammonia (100 mL) and evaporated in vacuo. The product was purified by preparative HPLC (XBridge column using a 95-40% gradient of aqueous 0.1% ammonia in acetonitrile as eluent). The fractions were evaporated to afford the title compound (0.050 g).

後処理

  1. temperaturebefore heating at 80° C. for 1 h
  2. extractionextracted with ethyl acetate (250 mL)
  3. dry with materialThe organic was dried (MgSO4)
  4. filtrationfiltered
  5. customevaporated
  6. customThe crude product was purified
  7. wash(SiO2 chromatography, elution 100% ethyl acetate)
  8. customPure fractions of [tert-butyl (2S)-4-[(6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-2-{[1-(hydroxymethyl)cyclopropyl]methyl}-1-oxo-1,2-dihydroisoquinolin-4-yl)methyl]-2-methylpiperazine-1-carboxylate] were evaporated to dryness
  9. additionThe mixture was treated with trifluoroacetic acid/DCM (1:1, 10 mL)
  10. stirringstirred for 1 h at room temperature
  11. customThe mixture was evaporated to dryness
  12. dissolutionthe crude material was dissolved in acetonitrile (25 mL)
  13. washThe impurities were washed through with acetonitrile (50 mL)
  14. washThe product was eluted with 1 N methanolic ammonia (100 mL)
  15. customevaporated in vacuo
  16. customThe product was purified by preparative HPLC (XBridge column
  17. customThe fractions were evaporated

出典と根拠

ORDレコード
ord-a2dc4626653342ad88395e1596d8fe79
出典データセット
uspto-grants-2011_09
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08012980B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート